三种方案治疗小儿肺炎的药物经济学研究

Study on pharmacoeconomics of three therapeutic regimes for infant pneumonia

目的 :比较三种方案治疗小儿细菌性肺炎的效率 (即费用—效果 )。方法 :2 0 0 1年～ 2 0 0 2年采用前瞻性随机临床试验A组5 0例、B组 5 0例、C组 5 0例作为分析模型 ,以深圳市二级甲等医院收费为标准 ,采用决策树的分析方法 ,进行费用—效果分析。结果 :每治疗 1例有效病人 ,A、B、C三组方案的期望成本分别为 470 7.45元、414 4.5 3元、3 0 5 2 .5 1元。结论 :同时考虑临床疗效及医疗费用 ,C组有最好的费用—效果 。

Objective: To assess the efficiency of three therapeutic regimes for infant pneumonia. Methods: Cost-effect analysis and decision tree analysis were based on a randomized controlled trial in infants with pneumonia in II A grade hospitals in Shenzhen in 2001～2002. Patients were divided into three groups, each of 50 cases. Results: For the three therapeutic regimes the anticipant costs of curing one case of infant pneumonia were 4707.45 yuan( group A),4144.53 yuan( group B) and 3052.51 yuan( group C) respectively. Conclusion: Considering the effectiveness and the costs,regime C is the best one.